We selected CpG candidates from our naïve CD4+ T-cell dataset, filtering CpGs, with a large size effect Δβ-value ≥ 10% between HC and RA patients (p-value ≤ 0.001). The gene discussed is CD4; the disease is rheumatoid arthritis.